The role of quantitative hepatitis B surface antigen revisited
In the past 10 years, there has been a lot of enthusiasm surrounding the use of serum
hepatitis B surface antigen (HBsAg) quantification to predict disease activity and monitor …
hepatitis B surface antigen (HBsAg) quantification to predict disease activity and monitor …
Hepatitis B virus genotypes and variants
CL Lin, JH Kao - Cold Spring Harbor …, 2015 - perspectivesinmedicine.cshlp.org
At least 10 hepatitis B virus (HBV) genotypes (A to J) with distinct geographic distributions
and several HBV mutants, including precore/core promoter mutations and pre-S/S deletion …
and several HBV mutants, including precore/core promoter mutations and pre-S/S deletion …
Yttrium‐90 radioembolization for the treatment of solitary, unresectable HCC: the LEGACY study
Conclusions Despite clear relationships between HBV RNA and HBcrAg levels and CHB
phases, these markers have limited additional value in differentiating CHB phases because …
phases, these markers have limited additional value in differentiating CHB phases because …
[图书][B] WHO guidelines on hepatitis B and C testing
World Health Organization - 2017 - apps.who.int
Web Annexes Page 1 Page | i GUIDELINES ON HEPATITIS B AND C TESTING February 2017
GUIDELINES ANNEXES Page 2 Page | ii WHO guidelines on hepatitis B and C testing ISBN …
GUIDELINES ANNEXES Page 2 Page | ii WHO guidelines on hepatitis B and C testing ISBN …
Serum hepatitis B core-related antigen (HBcrAg) correlates with covalently closed circular DNA transcriptional activity in chronic hepatitis B patients
B Testoni, F Lebossé, C Scholtes, F Berby… - Journal of …, 2019 - Elsevier
Background & Aims It has been proposed that serum hepatitis B core-related antigen
(HBcrAg) reflects intrahepatic covalently closed circular (ccc) DNA levels. However, the …
(HBcrAg) reflects intrahepatic covalently closed circular (ccc) DNA levels. However, the …
[HTML][HTML] EASL clinical practice guidelines: management of chronic hepatitis B virus infection
European Association For The Study Of The Liver - Journal of hepatology, 2012 - Elsevier
Our understanding of the natural history of hepatitis B virus (HBV) infection and the potential
for therapy of the resultant disease is continuously improving. New data have become …
for therapy of the resultant disease is continuously improving. New data have become …
[PDF][PDF] Transcriptomics identify thrombospondin‐2 as a biomarker for NASH and advanced liver fibrosis
K Kozumi, T Kodama, H Murai, S Sakane… - …, 2021 - Wiley Online Library
Background and Aims NAFLD is the most common liver disease worldwide. NASH, the
progressive form of NAFLD, and advanced fibrosis are associated with poor outcomes. We …
progressive form of NAFLD, and advanced fibrosis are associated with poor outcomes. We …
High levels of hepatitis B surface antigen increase risk of hepatocellular carcinoma in patients with low HBV load
BACKGROUND & AIMS: Patients with chronic hepatitis B virus (HBV) infection have a high
risk for developing hepatocellular carcinoma (HCC). Patients with lower levels of hepatitis B …
risk for developing hepatocellular carcinoma (HCC). Patients with lower levels of hepatitis B …
[图书][B] Guidelines for the prevention care and treatment of persons with chronic hepatitis B infection: Mar-15
World Health Organization - 2015 - books.google.com
These are the first World Health Organization (WHO) guidelines for the prevention care and
treatment of persons living with CHB infection and complement similar recent published …
treatment of persons living with CHB infection and complement similar recent published …
Prediction models of long‐term cirrhosis and hepatocellular carcinoma risk in chronic hepatitis B patients: risk scores integrating host and virus profiles
Integrating host and HBV characteristics, this study aimed to develop models for predicting
long‐term cirrhosis and hepatocellular carcinoma (HCC) risk in chronic hepatitis B virus …
long‐term cirrhosis and hepatocellular carcinoma (HCC) risk in chronic hepatitis B virus …